Huw M. Nash, COO & CBO at Stoke Therapeutics, Inc. (STOK), sold 5,732 shares at $59.85 ($338K) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $338k STOK by COO & CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.66 | 1,500 | $86K | 25.6% |
| 2 | $59.02 | 2,200 | $130K | 38.4% |
| 3 | $59.85 | 1,800 | $108K | 31.9% |
| 4 | $60.51 | 200 | $12K | 3.6% |
| 5 | $57.14 | 32 | $2K | 0.5% |
| Total | $58.97 avg | 5,732 |
| $338K |
| 100% |
| Filing → |
| STOK | SELL | 2024-04-03 | $1.6M | — | Filing → |
| STOK | SELL | 2024-03-19 | $25K | — | Filing → |
| STOK | SELL | 2022-01-05 | $88K | — | Filing → |